Neoadjuvant Pembrolizumab Not Tied to More AEs in Oral Cavity SCC
No increased perioperative morbidity seen among patients with local regionally advanced oral cavity squamous cell carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.